Llwytho...
Testosterone therapy in relation to prostate cancer in a US commercial insurance claims database
BACKGROUND: We conducted a study assess whether testosterone therapy (TT) alters prostate cancer risk using a large US commercial insurance research database. METHODS: From the HealthCore Integrated Research Database (HIRD(SM)), we selected men aged 30 years or greater who were new users of TT durin...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cancer Epidemiol Biomarkers Prev |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6954307/ https://ncbi.nlm.nih.gov/pubmed/31641011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-19-0619 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|